Latest news and events
Latest News from the Partnership
2021.03.02 | People
Norway's EMBL delegates, past and present
The EMBL (European Molecular Biology Laboratory) Council helps to guide EMBL's operations, administratively and scientifically.
2021.03.01 | Research news
Children and brain tumours: In search of a cure
Blog by NCMM group leader, Dr Sebastian Waszak: Whilst there has been good progress in treating many types of childhood cancer, some remain incurable. New precision medicine approach offers hope for young patients diagnosed with a rare and incurable brain tumour.
2021.02.19 | Research news
AI predicts efficacy of breast cancer treatment directly from tumor architecture
Researchers from the University of Helsinki have demonstrated the possibilities of artificial intelligence-based algorithms in predicting the efficacy of a targeted cancer therapy based on the tumour tissue architecture only, without specific molecular tests.
2021.02.16 | Research news
Secret to how cholera adapts to temperature revealed
Research from the Cava Group at MIMS and collaborators at EMBL Heidelberg and Ohio State University has discovered an essential protein in cholera-causing bacteria that allows them to adapt to changes in temperature. The study has been published in eLife.
2021.02.11 | News from the management
DANDRITE receives 75 million DKK from the Lundbeck Foundation for the continuation of DANDRITE from 2023-2028
The grant extends the ambitious neuroscience research initiative in Denmark and provides DANDRITE with the opportunity to continue until 2028. The prolongation of DANDRITE plays a key role in the Lundbeck Foundation's strategy to fund talent development in the field of neuroscience.
2021.02.01 | People
DANDRITE opens call for two new group leaders
Our DANISH node has two group leader positions available in Molecular and Translational Neuroscience
2021.01.19 | Research news
Major EU project will harness AI and genomics for disease prevention
An international collaboration project to develop and implement novel genome-based disease prediction tools has received over 10 million euros from the EU Horizon 2020 Research and Innovation program. The project aims to demonstrate the potential and benefits of powerful artificial intelligence (AI) technologies on the generation of genetic…
2021.01.06 | People
Nordic EMBL Partnership: Annual call for PhD students
The Nordic EMBL Partnership has opened its annual call for outstanding students seeking PhDs in molecular medicine
2020.12.15 | Research news
Novel genomic tools increase the accuracy of breast cancer risk assessment
Findings from the FinnGen study encompassing 120,000 women indicate that inherited breast cancer risk should be assessed in an increasingly comprehensive manner.
2020.12.11 | Research news
AI predicts which drug combinations kill cancer cells
A machine learning model developed in Finland, involving researchers at the Nordic EMBL Partnership's Finnish node, FIMM, can help us treat cancer more effectively.
Upcoming Partnership Events
No articles found in this list
News on publications
2021.02.01 | Publication
Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 Å resolution
The Luecke Group at NCMM have published in the journal Nature Communications
2021.02.01 | Publication
Binocular integration of retinal motion information underlies optic flow processing by the cortex
Rune Nguyen Rasmussen and Akihiro Matsumoto et al. from Keisuke Yonehara’s lab have published in Current Biology.
2020.11.26 | Publication
Biological lipid nanotubes and their potential role in evolution
Research from the Gözen group at NCMM published in The European Physical Journal Special Topics.
2020.09.10 | Publication
New publication from MIMS group leader Björn O. Schröder in JBC on function of microbiota in obese mice
The paper, 'Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice', has been published in the Journal of Biological Chemistry.
2020.09.10 | Publication
A high profile review article from MIMS group leader Barbara S. Sixt on host cell death modulation by the bacterial pathogen Chlamydia
The review has been published in the journal FEMS Microbiology Reviews.
2020.09.02 | Research news, Publication
Comment article: Predicting Cancer Evolution Using Cell State Dynamics
Dr Kuijjer's article, 'Predicting Evolution Using Cell State Dynamics', examines research using state transitions to model cancer development and progression.
2020.09.02 | Publication
Rapid Growth and Fusion of Protocells in Surface‐Adhered Membrane Networks
Elevated temperatures might have promoted the nucleation, growth, and replication of protocells on the early Earth.
2020.05.14 | Knowledge exchange, Publication
Joint efforts between Nabavi and Capogna group have led to the development of a novel approach named TRACE ´Tracing Retrogradely the Activated Cell Ensemble’
The neural circuitry teams at DANDRITE and PROMEMO introduce a novel approach in their latest publication, which selectively labels sensory inputs that are activated by a defined stimulus and directed to a region of interest in the brain.
2020.05.06 | Publication, Knowledge exchange
Gene variants that protect against glaucoma identified, opening therapeutic possibilities
An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the risk of glaucoma. The results open important new therapeutic possibilities.
2020.04.24 | Publication, Knowledge exchange
New work from the Esguerra group provides novel insight into disease mechanisms of Dravet syndrome
A new article from NCMM’s chemical neuroscience group published in Epilepsia sheds light on the early mechanisms underlying seizure onset in Dravet syndrome, a severe and devastating type of epilepsy that occurs in children and infants.
